Sensex rises for fourth day; Reliance, pharma lead
Goldman Sachs raised the target price on Reliance by 26 percent to 1,205 rupees and added the stock to its `conviction list` with a `buy` rating. The investment bank also expects the company`s core earnings to double over the next three years. Reliance shares gained as much as 2 percent.
Traders keep close track of stocks at the Bombay Stock Exchange headquarters. Photo: Zeebiz Team